Bath ASU Competitors and Similar CompaniesClear all

Bath ASU's competitors and similar companies include Travere Therapeutics, GBT (Global Blood Therapeutics), JCR Pharmaceuticals and Sosei Heptares.
Bath ASU
Bath ASU
Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
JCR Pharmaceuticals
JCR Pharmaceuticals
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
Sosei Heptares
Sosei Heptares
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Founding Date
Founding Date
2006
Founding Date
2011
Founding Date
2012
Founding Date
1975
Founding Date
1990
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Corsham, GB HQ
Locations
San Diego, US HQ
Dublin, IE
Locations
South San Francisco, US HQ
Paris, FR
Berlin, DE
Baar, CH
London, GB
Locations
Ashiya, JP HQ
Kobe, JP
Kobe, JP
Kobe, JP
Kobe, JP
Locations
Tokyo, JP HQ
Dublin, IE
Cambridge, GB
London, GB
Employees
Employees
905% decrease
Employees
46293% increase
Employees
352106% increase
Employees
879
Employees
37083% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
599.7 m
Valuation ($)
4.4 b
Valuation ($)
N/A
Valuation ($)
782.5 m
Twitter followers
Twitter followers
240
Twitter followers
15
Twitter followers
2.1 k
Twitter followers
N/A
Twitter followers
3 k
Employee Rating
Employee Rating
2.7
Employee Rating
4.4
Employee Rating
4.3
Employee Rating
5
Employee Rating
3.9

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$145.2m (FY, 2023)
Revenue (est.)
$194.7m (FY, 2021)
Revenue (est.)
¥34.3b (FY, 2023)
Revenue (est.)
¥15.6b (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
$11.5m (FY, 2023)
Cost of goods
$3.3m (FY, 2021)
Cost of goods
¥6.9b (FY, 2023)
Cost of goods
¥490m (FY, 2022)
Gross profit
Gross profit
N/A
Gross profit
$133.8m (FY, 2023)
Gross profit
N/A
Gross profit
¥27.5b (FY, 2023)
Gross profit
¥15.7b (FY, 2022)
Net income
Net income
N/A
Net income
($111.4m) (FY, 2023)
Net income
($303.1m) (FY, 2021)
Net income
¥3.8b (FY, 2023)
Net income
¥1.8b (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 25m
Total funding raised
$ 88.7m
Total funding raised
N/A
Total funding raised
$ 65m
For sources of this data, please see the company profile

View Company Profiles

Travere Therapeutics
HQ
San Diego, US
Employees
462

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company
JCR Pharmaceuticals
HQ
Ashiya, JP
Employees
879

JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.

View company
Sosei Heptares
HQ
Tokyo, JP
Employees
370

Sosei Heptares is a biopharmaceutical company that specializes in drug development.

View company